Wisconsin 340B bills

Four bills in the Wisconsin legislature name the 340B program. Here is what each one is, how far it has got and where to read it.

2025-2026 Regular Session

Ended 25 May 2026

  • Has a part on 340B
  • Payer and PBM non-discrimination

SB 203Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

In a wider bill on pharmacy benefit managers, would bar them from paying 340B covered entities and their contract pharmacies less than other pharmacies for a 340B drug, refusing to pay for 340B drugs, adding fees after a claim is paid, or limiting network access because of 340B.

Reported by committee21 August 2025Session ended 25 May 2026

Latest step
23 March 2026: Failed to pass pursuant to Senate Joint Resolution 1
Failed vote
23 March 2026: Failed to pass pursuant to Senate Joint Resolution 1
Sponsor
Felzkowski; Marklein; Cabral-Guevara; Dassler-Alfheim; Drake; Habush Sinykin; L. Johnson; Keyeski; Larson; Nass; Pfaff; Quinn; Ratcliff; Roys; Spreitzer; Wanggaard; Wimberger; James, with 22 cosponsors
Introduced
16 April 2025
Where it names 340B: SB 203

… service fees. 4. The amounts received from network pharmacies and pharmacists and the amount retained by the pharmacy benefit manager. Discriminatory reimbursement of 340B entities The bill prohibits a pharmacy benefit manager from taking certain actions with respect to 340B covered entities, pharmacies and pharmacists contracted with …

From the bill’s text. It names 340B 33 times.
  • Has a part on 340B
  • Payer and PBM non-discrimination

AB 62Relating to: health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE)

In a wider health care costs bill, would bar paying certain 340B entities (health centers, critical access hospitals, Ryan White grantees) and their pharmacies less for a 340B drug than similar-volume pharmacies, or charging them fees because they take part in 340B.

Introduced24 February 2025Session ended 25 May 2026

Latest step
23 March 2026: Failed to pass pursuant to Senate Joint Resolution 1
Failed vote
23 March 2026: Failed to pass pursuant to Senate Joint Resolution 1
Sponsor
Subeck; Spaude; Johnson; Anderson; Andraca; Arney; Bare; Billings; Brown; Cruz; DeSanto; DeSmidt; Doyle; Emerson; Fitzgerald; Goodwin; Haywood; Hong; Hysell; J. Jacobson; Joers; Kirsch; Madison; Mayadev; McCarville; McGuire; Miresse; Moore Omokunde; Neubauer; Ortiz-Velez; Palmeri; Phelps; Prado; Rivera-Wagner; Roe; Sheehan; Sinicki; Snodgrass; Stroud; Stubbs; Taylor; Tenorio; Udell; Vining, with 14 cosponsors
Where it names 340B: AB 62

… claims or bona fide service fees. 4. The amounts received from network pharmacies and the amount retained by the pharmacy benefit manager. Reimbursements for certain 340B program entities The bill prohibits any person from reimbursing certain entities that participate in the federal drug pricing program, known as the 340B program, for a …

From the bill’s text. It names 340B 4 times.
  • Has a part on 340B
  • Payer and PBM non-discrimination

AB 173Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

In a wider bill on pharmacy benefit managers, would bar them from paying 340B covered entities and their contract pharmacies less than other pharmacies for a 340B drug, refusing to pay for 340B drugs, adding fees after a claim is paid, or limiting network access because of 340B.

Introduced9 April 2025Session ended 25 May 2026

Latest step
23 March 2026: Failed to pass pursuant to Senate Joint Resolution 1
Failed vote
23 March 2026: Failed to pass pursuant to Senate Joint Resolution 1
Sponsor
Novak; Tranel; Allen; Armstrong; Brooks; Callahan; Fitzgerald; B. Jacobson; Joers; Kirsch; Kitchens; Knodl; Kreibich; McCarville; Miresse; Mursau; O'Connor; Sortwell; Tittl; Wichgers; Tucker, with 18 cosponsors
Where it names 340B: AB 173

… service fees. 4. The amounts received from network pharmacies and pharmacists and the amount retained by the pharmacy benefit manager. Discriminatory reimbursement of 340B entities The bill prohibits a pharmacy benefit manager from taking certain actions with respect to 340B covered entities, pharmacies and pharmacists contracted with …

From the bill’s text. It names 340B 33 times.
  • Has a part on 340B
  • Payer and PBM non-discrimination

SB 50Relating to: health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE)

In a wider health care costs bill, would bar paying certain 340B entities (health centers, critical access hospitals, Ryan White grantees) and their pharmacies less for a 340B drug than similar-volume pharmacies, or charging them fees because they take part in 340B.

Introduced21 February 2025Session ended 25 May 2026

Latest step
23 March 2026: Failed to pass pursuant to Senate Joint Resolution 1
Failed vote
23 March 2026: Failed to pass pursuant to Senate Joint Resolution 1
Sponsor
Pfaff; Hesselbein; Drake; Carpenter; Dassler-Alfheim; Habush Sinykin; L. Johnson; Keyeski; Ratcliff; Roys; Smith; Spreitzer; Wall; Wirch, with 42 cosponsors
Where it names 340B: SB 50

… claims or bona fide service fees. 4. The amounts received from network pharmacies and the amount retained by the pharmacy benefit manager. Reimbursements for certain 340B program entities The bill prohibits any person from reimbursing certain entities that participate in the federal drug pricing program, known as the 340B program, for a …

From the bill’s text. It names 340B 4 times.

A bill is a proposal, not law. Most bills never pass, and a bill can change at every step. Read the legislature’s own page before you rely on one.

See something missing or out of date? Tell us.